TreeWAS – Variant ID: rs35909033

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
I60-I69 Cerebrovascular diseases	1.000	0.000
Chapter VI Diseases of the nervous system	1.000	0.000
Chapter IX Diseases of the circulatory system	1.000	0.000
# Top node	1.000	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	1.000	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	1.000	0.000
G81 Hemiplegia	0.999	0.001
G81.9 Hemiplegia, unspecified	0.999	0.001
Chapter VIII Diseases of the ear and mastoid process	0.998	0.002
I69 Sequelae of cerebrovascular disease	0.997	0.003
I10-I15 Hypertensive diseases	0.996	0.004
I67 Other cerebrovascular diseases	0.996	0.004
G40-G47 Episodic and paroxysmal disorders	0.992	0.008
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.988	0.012
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.987	0.013
H65-H75 Diseases of middle ear and mastoid	0.986	0.014
L50-L54 Urticaria and erythema	0.981	0.019
I67.9 Cerebrovascular disease, unspecified	0.977	0.023
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.974	0.026
H90-H95 Other disorders of ear	0.974	0.026
H66 Suppurative and unspecified otitis media	0.973	0.027
L80-L99 Other disorders of the skin and subcutaneous tissue	0.971	0.029
G40 Epilepsy	0.969	0.031
I10 Essential (primary) hypertension	0.967	0.033
L00-L08 Infections of the skin and subcutaneous tissue	0.963	0.037
I12 Hypertensive renal disease	0.960	0.040
R21 Rash and other nonspecific skin eruption	0.959	0.041
H66.9 Otitis media, unspecified	0.952	0.048
I63 Cerebral infarction	0.949	0.051
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.944	0.056
R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour	0.939	0.061
L03 Cellulitis	0.939	0.061
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.933	0.067
L03.1 Cellulitis of other parts of limb	0.925	0.075
I67.8 Other specified cerebrovascular diseases	0.917	0.083
I61 Intracerebral haemorrhage	0.917	0.083
L53 Other erythematous conditions	0.917	0.083
L97 Ulcer of lower limb, not elsewhere classified	0.915	0.085
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.915	0.085
I69.3 Sequelae of cerebral infarction	0.911	0.089
I12.0 Hypertensive renal disease with renal failure	0.906	0.094
R47-R49 Symptoms and signs involving speech and voice	0.905	0.095
H90 Conductive and sensorineural hearing loss	0.904	0.096
G30-G32 Other degenerative diseases of the nervous system	0.898	0.102
L50 Urticaria	0.897	0.103
R20 Disturbances of skin sensation	0.896	0.104
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.895	0.105
G47 Sleep disorders	0.894	0.106
Chapter V Mental and behavioural disorders	0.886	0.114
G43 Migraine	0.884	0.116
I30-I52 Other forms of heart disease	0.882	0.118
L53.9 Erythematous condition, unspecified	0.875	0.125
H92 Otalgia and effusion of ear	0.875	0.125
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.875	0.125
L89 Decubitus ulcer	0.873	0.127
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.872	0.128
H90.5 Sensorineural hearing loss, unspecified	0.866	0.134
I45 Other conduction disorders	0.863	0.137
G82 Paraplegia and tetraplegia	0.861	0.139
L20-L30 Dermatitis and eczema	0.861	0.139
R25 Abnormal involuntary movements	0.860	0.140
I42 Cardiomyopathy	0.859	0.141
L93 Lupus erythematosus	0.855	0.145
L08 Other local infections of skin and subcutaneous tissue	0.854	0.146
G43.1 Migraine with aura [classical migraine]	0.849	0.151
I42.9 Cardiomyopathy, unspecified	0.845	0.155
H93 Other disorders of ear, not elsewhere classified	0.840	0.160
I12.9 Hypertensive renal disease without renal failure	0.833	0.167
I69.0 Sequelae of subarachnoid haemorrhage	0.833	0.167
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.832	0.168
G70-G73 Diseases of myoneural junction and muscle	0.831	0.169
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.822	0.178
H66.3 Other chronic suppurative otitis media	0.819	0.180
Chapter I Certain infectious and parasitic diseases	0.818	0.182
I61.5 Intracerebral haemorrhage, intraventricular	0.817	0.183
Chapter XX External causes of morbidity and mortality	0.817	0.183
L95 Vasculitis limited to skin, not elsewhere classified	0.815	0.185
G40.8 Other epilepsy	0.814	0.186
L30 Other dermatitis	0.813	0.187
Q38-Q45 Other congenital malformations of the digestive system	0.811	0.189
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.808	0.192
G47.3 Sleep apnoea	0.808	0.192
Y60-Y69 Misadventures to patients during surgical and medical care	0.805	0.195
I45.1 Other and unspecified right bundle-branch block	0.803	0.197
H74 Other disorders of middle ear and mastoid	0.802	0.198
R47 Speech disturbances, not elsewhere classified	0.798	0.202
L03.2 Cellulitis of face	0.796	0.204
L10-L14 Bullous disorders	0.795	0.205
R42 Dizziness and giddiness	0.795	0.205
Q60-Q64 Congenital malformations of the urinary system	0.795	0.205
F00-F09 Organic, including symptomatic, mental disorders	0.794	0.206
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.793	0.207
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.788	0.212
L89.0 Stage I decubitus ulcer and pressure area	0.787	0.213
R43 Disturbances of smell and taste	0.786	0.214
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.786	0.214
Y60.0 During surgical operation	0.785	0.215
H65 Nonsuppurative otitis media	0.784	0.216
R20.8 Other and unspecified disturbances of skin sensation	0.784	0.216
L30.9 Dermatitis, unspecified	0.784	0.216
I80 Phlebitis and thrombophlebitis	0.783	0.217
R45 Symptoms and signs involving emotional state	0.783	0.217
I67.1 Cerebral aneurysm, nonruptured	0.781	0.219
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.781	0.219
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.778	0.222
F80-F89 Disorders of psychological development	0.778	0.222
I15 Secondary hypertension	0.776	0.223
L52 Erythema nodosum	0.775	0.225
G83 Other paralytic syndromes	0.772	0.228
G20-G26 Extrapyramidal and movement disorders	0.771	0.229
R27 Other lack of coordination	0.769	0.231
G11 Hereditary ataxia	0.768	0.232
H66.1 Chronic tubotympanic suppurative otitis media	0.764	0.236
R41 Other symptoms and signs involving cognitive functions and awareness	0.763	0.237
G40.9 Epilepsy, unspecified	0.762	0.238
H92.1 Otorrhoea	0.762	0.238
R49 Voice disturbances	0.762	0.238
H71 Cholesteatoma of middle ear	0.758	0.242
I30 Acute pericarditis	0.758	0.242
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.758	0.242
I67.2 Cerebral atherosclerosis	0.755	0.245
I67.0 Dissection of cerebral arteries, nonruptured	0.755	0.245
L50.1 Idiopathic urticaria	0.752	0.248
R46 Symptoms and signs involving appearance and behaviour	0.749	0.251
B35-B49 Mycoses	0.749	0.251
I46 Cardiac arrest	0.747	0.253
I95-I99 Other and unspecified disorders of the circulatory system	0.747	0.253
I45.8 Other specified conduction disorders	0.746	0.254
H73 Other disorders of tympanic membrane	0.745	0.255
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.744	0.256
H69 Other disorders of Eustachian tube	0.744	0.256
M70-M79 Other soft tissue disorders	0.744	0.256
L03.0 Cellulitis of finger and toe	0.743	0.257
G62 Other polyneuropathies	0.742	0.258
H80-H83 Diseases of inner ear	0.740	0.260
L98.8 Other specified disorders of skin and subcutaneous tissue	0.739	0.261
H93.1 Tinnitus	0.739	0.261
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.735	0.265
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.734	0.266
R25.1 Tremor, unspecified	0.734	0.266
R70-R79 Abnormal findings on examination of blood, without diagnosis	0.734	0.266
G90-G99 Other disorders of the nervous system	0.734	0.266
M86-M90 Other osteopathies	0.734	0.266
M75 Shoulder lesions	0.733	0.267
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.733	0.267
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.730	0.270
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.730	0.270
G61 Inflammatory polyneuropathy	0.729	0.271
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.729	0.271
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.729	0.271
R20.0 Anaesthesia of skin	0.729	0.271
G30 Alzheimer's disease	0.729	0.271
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.728	0.272
L51 Erythema multiforme	0.727	0.273
G44 Other headache syndromes	0.725	0.275
Q20-Q28 Congenital malformations of the circulatory system	0.725	0.275
R47.0 Dysphasia and aphasia	0.724	0.276
H65.9 Nonsuppurative otitis media, unspecified	0.721	0.279
I45.6 Preexcitation syndrome	0.720	0.280
R25.8 Other and unspecified abnormal involuntary movements	0.719	0.281
H92.0 Otalgia	0.719	0.281
I62 Other nontraumatic intracranial haemorrhage	0.719	0.281
L80 Vitiligo	0.718	0.282
L93.1 Subacute cutaneous lupus erythematosus	0.718	0.282
L89.9 Decubitus ulcer and pressure area, unspecified	0.718	0.282
I68 Cerebrovascular disorders in diseases classified elsewhere	0.717	0.283
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.717	0.283
I00-I02 Acute rheumatic fever	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
Q50-Q56 Congenital malformations of genital organs	0.717	0.283
G81.1 Spastic hemiplegia	0.717	0.283
G81.0 Flaccid hemiplegia	0.717	0.283
I61.4 Intracerebral haemorrhage in cerebellum	0.716	0.284
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.715	0.285
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.714	0.286
I13 Hypertensive heart and renal disease	0.714	0.286
I67.7 Cerebral arteritis, not elsewhere classified	0.714	0.286
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.714	0.286
I67.5 Moyamoya disease	0.714	0.286
I67.4 Hypertensive encephalopathy	0.714	0.286
I67.3 Progressive vascular leukoencephalopathy	0.714	0.286
G82.5 Tetraplegia, unspecified	0.714	0.286
G46 Vascular syndromes of brain in cerebrovascular diseases	0.711	0.289
L50.0 Allergic urticaria	0.711	0.289
L50.8 Other urticaria	0.710	0.290
F40-F48 Neurotic, stress-related and somatoform disorders	0.709	0.291
R95-R99 Ill-defined and unknown causes of mortality	0.708	0.292
I42.6 Alcoholic cardiomyopathy	0.707	0.293
L93.0 Discoid lupus erythematosus	0.707	0.293
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.707	0.293
H70 Mastoiditis and related conditions	0.707	0.293
H68 Eustachian salpingitis and obstruction	0.707	0.293
H67 Otitis media in diseases classified elsewhere	0.707	0.293
I61.8 Other intracerebral haemorrhage	0.706	0.294
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.706	0.294
R20.2 Paraesthesia of skin	0.706	0.294
I60 Subarachnoid haemorrhage	0.706	0.294
L54 Erythema in diseases classified elsewhere	0.703	0.297
B37 Candidiasis	0.703	0.297
G40.5 Special epileptic syndromes	0.702	0.298
L95.9 Vasculitis limited to skin, unspecified	0.702	0.298
I11 Hypertensive heart disease	0.702	0.298
I82 Other venous embolism and thrombosis	0.701	0.299
L83 Acanthosis nigricans	0.699	0.301
L50.9 Urticaria, unspecified	0.699	0.301
M75.5 Bursitis of shoulder	0.699	0.301
R44 Other symptoms and signs involving general sensations and perceptions	0.699	0.301
G47.9 Sleep disorder, unspecified	0.699	0.301
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.698	0.302
H94 Other disorders of ear in diseases classified elsewhere	0.698	0.302
H66.4 Suppurative otitis media, unspecified	0.698	0.302
H66.2 Chronic atticoantral suppurative otitis media	0.698	0.302
H66.0 Acute suppurative otitis media	0.698	0.302
H60-H62 Diseases of external ear	0.697	0.303
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.696	0.304
L94 Other localised connective tissue disorders	0.696	0.304
L87 Transepidermal elimination disorders	0.696	0.304
L88 Pyoderma gangrenosum	0.696	0.304
L86 Keratoderma in diseases classified elsewhere	0.696	0.304
I05-I09 Chronic rheumatic heart diseases	0.696	0.304
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.696	0.304
R25.3 Fasciculation	0.695	0.305
M40-M43 Deforming dorsopathies	0.695	0.305
G40.7 Petit mal, unspecified, without grand mal seizures	0.694	0.305
G40.4 Other generalised epilepsy and epileptic syndromes	0.694	0.305
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.694	0.305
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.693	0.307
G11.9 Hereditary ataxia, unspecified	0.693	0.307
F05 Delirium, not induced by alcohol and other psychoactive substances	0.693	0.307
I47 Paroxysmal tachycardia	0.692	0.308
G47.1 Disorders of excessive somnolence [hypersomnias]	0.692	0.308
I85 Oesophageal varices	0.691	0.309
L04 Acute lymphadenitis	0.690	0.309
L01 Impetigo	0.690	0.309
L00 Staphylococcal scalded skin syndrome	0.690	0.309
R80 Isolated proteinuria	0.689	0.311
A30-A49 Other bacterial diseases	0.687	0.313
I63.8 Other cerebral infarction	0.686	0.314
R49.0 Dysphonia	0.685	0.315
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.685	0.315
R27.0 Ataxia, unspecified	0.685	0.315
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.683	0.317
G41 Status epilepticus	0.683	0.317
Q38 Other congenital malformations of tongue, mouth and pharynx	0.681	0.319
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.680	0.320
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.680	0.320
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.680	0.320
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.679	0.321
G63 Polyneuropathy in diseases classified elsewhere	0.679	0.321
I98 Other disorders of circulatory system in diseases classified elsewhere	0.679	0.321
I80.8 Phlebitis and thrombophlebitis of other sites	0.679	0.321
G00-G09 Inflammatory diseases of the central nervous system	0.677	0.322
G82.1 Spastic paraplegia	0.677	0.323
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.677	0.323
Q35-Q37 Cleft lip and cleft palate	0.677	0.323
Q30-Q34 Congenital malformations of the respiratory system	0.677	0.323
Q60 Renal agenesis and other reduction defects of kidney	0.675	0.325
L89.3 Stage IV decubitus ulcer	0.674	0.326
H74.8 Other specified disorders of middle ear and mastoid	0.674	0.326
G47.8 Other sleep disorders	0.673	0.327
M75.0 Adhesive capsulitis of shoulder	0.673	0.327
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.672	0.328
G25 Other extrapyramidal and movement disorders	0.672	0.328
G60 Hereditary and idiopathic neuropathy	0.671	0.329
I45.5 Other specified heart block	0.670	0.330
I30.9 Acute pericarditis, unspecified	0.669	0.331
G31.9 Degenerative disease of nervous system, unspecified	0.667	0.333
Q80-Q89 Other congenital malformations	0.667	0.333
R45.2 Unhappiness	0.666	0.334
F80 Specific developmental disorders of speech and language	0.666	0.334
I46.0 Cardiac arrest with successful resuscitation	0.665	0.335
Chapter VII Diseases of the eye and adnexa	0.665	0.335
L81 Other disorders of pigmentation	0.665	0.335
G70 Myasthenia gravis and other myoneural disorders	0.665	0.335
R25.2 Cramp and spasm	0.663	0.337
I33 Acute and subacute endocarditis	0.663	0.337
B37.8 Candidiasis of other sites	0.660	0.340
I45.9 Conduction disorder, unspecified	0.659	0.341
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.658	0.342
R82 Other abnormal findings in urine	0.658	0.342
I61.6 Intracerebral haemorrhage, multiple localised	0.658	0.342
I61.3 Intracerebral haemorrhage in brain stem	0.658	0.342
L53.3 Other chronic figurate erythema	0.657	0.342
L53.2 Erythema marginatum	0.657	0.342
L53.1 Erythema annulare centrifugum	0.657	0.342
L53.0 Toxic erythema	0.657	0.342
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.657	0.343
G12 Spinal muscular atrophy and related syndromes	0.656	0.344
L84 Corns and callosities	0.653	0.347
G80 Infantile cerebral palsy	0.651	0.349
R72 Abnormality of white blood cells, not elsewhere classified	0.651	0.349
I42.8 Other cardiomyopathies	0.650	0.350
R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified	0.649	0.351
I61.9 Intracerebral haemorrhage, unspecified	0.648	0.352
R47.8 Other and unspecified speech disturbances	0.647	0.353
Y86 Sequelae of other accidents	0.647	0.353
R23 Other skin changes	0.645	0.355
G82.2 Paraplegia, unspecified	0.645	0.355
Q43 Other congenital malformations of intestine	0.644	0.356
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.644	0.356
Q66 Congenital deformities of feet	0.643	0.357
L50.6 Contact urticaria	0.643	0.357
L50.5 Cholinergic urticaria	0.643	0.357
L50.4 Vibratory urticaria	0.643	0.357
L50.3 Dermatographic urticaria	0.643	0.357
L50.2 Urticaria due to cold and heat	0.643	0.357
R20.3 Hyperaesthesia	0.643	0.357
R20.1 Hypoaesthesia of skin	0.643	0.357
G62.9 Polyneuropathy, unspecified	0.642	0.358
G64 Other disorders of peripheral nervous system	0.642	0.358
M43 Other deforming dorsopathies	0.641	0.359
L03.9 Cellulitis, unspecified	0.641	0.359
G47.2 Disorders of the sleep-wake schedule	0.641	0.359
G47.4 Narcolepsy and cataplexy	0.640	0.360
G93 Other disorders of brain	0.639	0.361
H90.2 Conductive hearing loss, unspecified	0.639	0.361
Y65 Other misadventures during surgical and medical care	0.638	0.362
V20-V29 Motorcycle rider injured in transport accident	0.638	0.362
M89 Other disorders of bone	0.637	0.363
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.636	0.364
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.635	0.365
F70-F79 Mental retardation	0.635	0.365
G72 Other myopathies	0.635	0.365
I45.3 Trifascicular block	0.635	0.365
L53.8 Other specified erythematous conditions	0.634	0.365
G43.3 Complicated migraine	0.634	0.366
G43.2 Status migrainosus	0.634	0.366
G43.0 Migraine without aura [common migraine]	0.634	0.366
X20-X29 Contact with venomous animals and plants	0.634	0.366
R41.3 Other amnesia	0.634	0.366
I34 Nonrheumatic mitral valve disorders	0.633	0.367
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.633	0.367
I82.8 Embolism and thrombosis of other specified veins	0.633	0.367
L05 Pilonidal cyst	0.633	0.367
I52 Other heart disorders in diseases classified elsewhere	0.632	0.367
I48 Atrial fibrillation and flutter	0.632	0.367
I43 Cardiomyopathy in diseases classified elsewhere	0.632	0.367
I41 Myocarditis in diseases classified elsewhere	0.632	0.367
I40 Acute myocarditis	0.632	0.367
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.632	0.367
I32 Pericarditis in diseases classified elsewhere	0.632	0.367
L12 Pemphigoid	0.632	0.368
L28 Lichen simplex chronicus and prurigo	0.632	0.368
I69.1 Sequelae of intracerebral haemorrhage	0.631	0.368
R43.0 Anosmia	0.631	0.369
I98.2 Oesophageal varices in diseases classified elsewhere	0.630	0.370
H04 Disorders of lachrymal system	0.630	0.370
R43.8 Other and unspecified disturbances of smell and taste	0.629	0.370
L82 Seborrhoeic keratosis	0.627	0.373
H92.2 Otorrhagia	0.627	0.373
I47.1 Supraventricular tachycardia	0.627	0.373
H02 Other disorders of eyelid	0.626	0.374
L91 Hypertrophic disorders of skin	0.626	0.374
H04.5 Stenosis and insufficiency of lachrymal passages	0.626	0.374
F81 Specific developmental disorders of scholastic skills	0.626	0.374
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.625	0.374
G14 Postpolio syndrome	0.625	0.374
G10 Huntington's disease	0.625	0.374
H74.9 Disorder of middle ear and mastoid, unspecified	0.625	0.375
G71 Primary disorders of muscles	0.625	0.375
G31.8 Other specified degenerative diseases of nervous system	0.624	0.376
H74.3 Other acquired abnormalities of ear ossicles	0.619	0.381
I45.4 Nonspecific intraventricular block	0.619	0.381
I45.0 Right fascicular block	0.619	0.381
M87 Osteonecrosis	0.618	0.382
G82.4 Spastic tetraplegia	0.618	0.382
G82.3 Flaccid tetraplegia	0.618	0.382
G82.0 Flaccid paraplegia	0.618	0.382
R44.3 Hallucinations, unspecified	0.617	0.382
L25 Unspecified contact dermatitis	0.617	0.382
L24 Irritant contact dermatitis	0.617	0.382
L23 Allergic contact dermatitis	0.617	0.382
L21 Seborrhoeic dermatitis	0.617	0.382
L26 Exfoliative dermatitis	0.617	0.382
L22 Diaper [napkin] dermatitis	0.617	0.382
F03 Unspecified dementia	0.617	0.383
H83 Other diseases of inner ear	0.617	0.383
H93.9 Disorder of ear, unspecified	0.617	0.383
R25.0 Abnormal head movements	0.616	0.383
I42.7 Cardiomyopathy due to drugs and other external agents	0.616	0.384
I42.5 Other restrictive cardiomyopathy	0.616	0.384
I42.4 Endocardial fibroelastosis	0.616	0.384
I42.3 Endomyocardial (eosinophilic) disease	0.616	0.384
M75.9 Shoulder lesion, unspecified	0.615	0.385
I15.9 Seconday hypertension, unspecified	0.615	0.385
L20 Atopic dermatitis	0.614	0.386
I37 Pulmonary valve disorders	0.614	0.386
I63.9 Cerebral infarction, unspecified	0.614	0.386
H90.0 Conductive hearing loss, bilateral	0.614	0.386
L93.2 Other local lupus erythematosus	0.613	0.387
L08.1 Erythrasma	0.612	0.388
L08.0 Pyoderma	0.612	0.388
X50-X57 Overexertion, travel and privation	0.612	0.388
F99-F99 Unspecified mental disorder	0.611	0.388
B95-B98 Bacterial, viral and other infectious agents	0.611	0.389
G30.9 Alzheimer's disease, unspecified	0.610	0.390
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.609	0.391
G91 Hydrocephalus	0.609	0.391
A80-A89 Viral infections of the central nervous system	0.608	0.392
L85 Other epidermal thickening	0.607	0.392
Q63 Other congenital malformations of kidney	0.606	0.394
G44.4 Drug-induced headache, not elsewhere classified	0.605	0.395
A49 Bacterial infection of unspecified site	0.603	0.397
H93.8 Other specified disorders of ear	0.602	0.397
H93.3 Disorders of acoustic nerve	0.602	0.397
H93.2 Other abnormal auditory perceptions	0.602	0.397
H93.0 Degenerative and vascular disorders of ear	0.602	0.397
G83.8 Other specified paralytic syndromes	0.602	0.398
G31.2 Degeneration of nervous system due to alcohol	0.600	0.400
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.600	0.400
B99-B99 Other infectious diseases	0.599	0.401
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.599	0.401
X58-X59 Accidental exposure to other and unspecified factors	0.597	0.403
G83.1 Monoplegia of lower limb	0.596	0.403
B25-B34 Other viral diseases	0.596	0.404
B65-B83 Helminthiases	0.596	0.404
R84 Abnormal findings in specimens from respiratory organs and thorax	0.596	0.404
Q00-Q07 Congenital malformations of the nervous system	0.596	0.404
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.596	0.404
A40 Streptococcal septicaemia	0.595	0.405
B50-B64 Protozoal diseases	0.595	0.405
F29 Unspecified nonorganic psychosis	0.595	0.405
I42.2 Other hypertrophic cardiomyopathy	0.594	0.406
G83.2 Monoplegia of upper limb	0.593	0.407
F02 Dementia in other diseases classified elsewhere	0.593	0.407
G43.8 Other migraine	0.592	0.407
L13 Other bullous disorders	0.592	0.407
F00 Dementia in Alzheimer's disease	0.592	0.408
M86 Osteomyelitis	0.592	0.408
M91-M94 Chondropathies	0.590	0.410
Q60.0 Renal agenesis, unilateral	0.590	0.410
R45.8 Other symptoms and signs involving emotional state	0.590	0.410
R77 Other abnormalities of plasma proteins	0.589	0.411
Y85 Sequelae of transport accidents	0.589	0.411
Q38.7 Pharyngeal pouch	0.588	0.412
R46.8 Other symptoms and signs involving appearance and behaviour	0.588	0.412
B90-B94 Sequelae of infectious and parasitic diseases	0.588	0.412
M43.1 Spondylolisthesis	0.588	0.412
I05 Rheumatic mitral valve diseases	0.588	0.412
B85-B89 Pediculosis, acariasis and other infestations	0.587	0.413
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.587	0.413
A75-A79 Rickettsioses	0.587	0.413
A70-A74 Other diseases caused by chlamydiae	0.587	0.413
A65-A69 Other spirochaetal diseases	0.587	0.413
A20-A28 Certain zoonotic bacterial diseases	0.587	0.413
A15-A19 Tuberculosis	0.587	0.413
I85.9 Oesophageal varices without bleeding	0.586	0.413
Y35-Y36 Legal intervention and operations of war	0.586	0.414
Y10-Y34 Event of undetermined intent	0.586	0.414
Y00-Y09 Assault	0.586	0.414
X85-X99 Assault	0.586	0.414
X30-X39 Exposure to forces of nature	0.586	0.414
X10-X19 Contact with heat and hot substances	0.586	0.414
X00-X09 Exposure to smoke, fire and flames	0.586	0.414
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.586	0.414
W75-W84 Other accidental threats to breathing	0.586	0.414
W65-W74 Accidental drowning and submersion	0.586	0.414
V98-V99 Other and unspecified transport accidents	0.586	0.414
V95-V97 Air and space transport accidents	0.586	0.414
V90-V94 Water transport accidents	0.586	0.414
V70-V79 Bus occupant injured in transport accident	0.586	0.414
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.586	0.414
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.586	0.414
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.586	0.414
V01-V09 Pedestrian injured in transport accident	0.586	0.414
H02.3 Blepharochalasis	0.586	0.414
F80.1 Expressive language disorder	0.586	0.414
G25.8 Other specified extrapyramidal and movement disorders	0.585	0.415
L95.8 Other vasculitis limited to skin	0.584	0.416
L95.1 Erythema elevatum diutinum	0.584	0.416
L95.0 Livedoid vasculitis	0.584	0.416
R81 Glycosuria	0.584	0.416
L30.5 Pityriasis alba	0.583	0.417
L30.4 Erythema intertrigo	0.583	0.417
L30.3 Infective dermatitis	0.583	0.417
L30.2 Cutaneous autosensitisation	0.583	0.417
L30.1 Dyshidrosis [pompholyx]	0.583	0.417
L30.0 Nummular dermatitis	0.583	0.417
I97 Postprocedural disorders of circulatory system, not elsewhere classified	0.583	0.417
Q45 Other congenital malformations of digestive system	0.581	0.419
Q42 Congenital absence, atresia and stenosis of large intestine	0.581	0.419
Q41 Congenital absence, atresia and stenosis of small intestine	0.581	0.419
Q40 Other congenital malformations of upper alimentary tract	0.581	0.419
Q39 Congenital malformations of oesophagus	0.581	0.419
Q28 Other congenital malformations of circulatory system	0.581	0.419
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.581	0.419
W20-W49 Exposure to inanimate mechanical forces	0.580	0.420
B37.1 Pulmonary candidiasis	0.580	0.420
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.580	0.420
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.579	0.421
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.578	0.422
F05.9 Delirium, unspecified	0.577	0.423
Y64 Contaminated medical or biological substances	0.577	0.423
Y63 Failure in dosage during surgical and medical care	0.577	0.423
Y62 Failure of sterile precautions during surgical and medical care	0.577	0.423
Y61 Foreign object accidentally left in body during surgical and medical care	0.577	0.423
Y69 Unspecified misadventure during surgical and medical care	0.577	0.423
Y66 Nonadministration of surgical and medical care	0.577	0.423
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.576	0.423
L08.8 Other specified local infections of skin and subcutaneous tissue	0.576	0.424

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations